{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:55:48Z","timestamp":1788976548630,"version":"build-2803163510"},"reference-count":19,"publisher":"ALUNA","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wiad Lek"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Aim: To compare X-ray signs in different gestational and body weight groups of patients with NEC.\nMaterials and Methods: We conducted a retrospective study, enrolling 52 preterm newborns with symptoms of NEC regardless of onset time, who underwent treatment at Neonatal Intensive Care Units in Municipal Non-commercial enterprise \u201cCity Children Hospital \u21162\u201d, Odesa. The patients were split into 3 clinical groups: very preterm newborns (VPN), moderately preterm newborns (MPN), and moderately preterm newborns with intrauterine growth restriction (MPN+IUGR).\nResults: In the VPN group NEC was diagnosed at stage II (58,82\u0081}12,30) % and III (41,18\u0081}12,30) % by Bell MJ, \u0440&gt;0,05. In the group MPN+IUGR, NEC stage II (33,33\u0081}14,21) % and stage III (66,66 \u0081}14,21) %, \u0440&gt;0,05, were equally observed. In the MPN group, NEC was diagnosed at stage I (41,67\u0081}10,28) % and II (58,33\u0081}10,28) %, \u0440&gt;0,05, without prevalence of any. Also only localized forms were observed. In VPN, we observed localized forms in most cases, while diffuse forms were diagnosed in (11,76\u0081}8,05) % cases, \u0440&lt;0,05. In the MPN+IUGR group, we found diffuse form of the NEC in half of the cases \u2013 (50,00\u0081}15,08) %. In the VPN and MPN+IUGR groups, NEC developed at 13,23\u0081}0,39 and 14,33\u0081}1,19 days, respectively. However, in MPN without IUGR, NEC developed at 17,75\u0081}0,55 days, significantly later than in the MPN+IUGR group, \u0440&lt;0,05.\nConclusions: We have described distinct features of NEC in MPN with IUGR. Compared to MPN without IUGR, NEC had more severe course and earlier manifestation in such neonates.<\/jats:p>","DOI":"10.36740\/wlek202403106","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T17:02:02Z","timestamp":1714582922000},"page":"409-416","source":"Crossref","is-referenced-by-count":1,"title":["Necrotizing enterocolitis in premature infants at different gestation ages"],"prefix":"10.36740","volume":"77","author":[{"given":"Kateryna","family":"Doikova","sequence":"first","affiliation":[{"name":"BARUCH PADEH MEDICAL CENTER, PORIA, ISRAEL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Jerdev","sequence":"additional","affiliation":[{"name":"BARUCH PADEH MEDICAL CENTER, PORIA, ISRAEL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larysa","family":"Koval","sequence":"additional","affiliation":[{"name":"ODESA NATIONAL MEDICAL UNIVERSITY, ODESA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Valantsevych","sequence":"additional","affiliation":[{"name":"COMMUNAL NONPROFIT ENTERPRISE \u201cCITY CLINICAL HOSPITAL \u211611\u201d ODESA CITY COUNCIL, ODESA, UKRAINE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22436","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Garg PM, Paschal JL, Ansari MAY et al. Clinical outcomes and gestational age based prediction of pneumatosis intestinalis in preterm infants with necrotizing enterocolitis. J Neonatal Perinatal Med. 2022;15(4):803-812. doi: 10.3233\/NPM-210971.","DOI":"10.3233\/npm-210971"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Aurora M, Keyes ML, Acosta JG et al. Standardizing the Evaluation and Management of Necrotizing Enterocolitis in a Level IV NICU. Pediatrics. 2022;150(4): e2022056616.. doi: 10.1542\/peds.2022-056616.","DOI":"10.1542\/peds.2022-056616"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Frid G, Reppucci M, Lum T et al. Comparison of Necrotizing Enterocolitis in Pre-mature Infants vs. Term-Born Infants With Congenital Heart Disease. Front Pediatr. 2021;20:9:802607. doi: 10.3389\/fped.2021.802607.","DOI":"10.3389\/fped.2021.802607"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Alsaied A, Islam N, Thalib L. Global incidence of Necrotizing Enterocolitis: a systematic review and Meta-analysis. BMC Pediatr. 2020;20(1):344. doi: 10.1186\/s12887-020-02231-5.","DOI":"10.1186\/s12887-020-02231-5"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Singh DK, Miller CM, Orgel KA et al. Necrotizing enterocolitis: Bench to bedside approaches and advancing our understanding of disease pathogenesis. Front Pediatr. 2023;10:1107404. doi: 10.3389\/fped.2022.1107404.","DOI":"10.3389\/fped.2022.1107404"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255-64. doi: 10.1056\/NEJMra1005408.","DOI":"10.1056\/NEJMra1005408"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs. 2008;68(9):1227- 38. doi: 10.2165\/00003495-200868090-00004.","DOI":"10.2165\/00003495-200868090-00004"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Ahle M, Ringertz HG, Rubesova E. The role of imaging in the management of necrotising enterocolitis: a multispecialist survey and a review of the literature. Eur Radiol. 2018;28(9):3621-3631. doi: 10.1007\/s00330-018-5362-x.","DOI":"10.1007\/s00330-018-5362-x"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Alganabi M, Lee C, Bindi E, Li B et al. Recent advances in understanding necrotizing enterocolitis. F1000Res. 2019;25:8:F1000. doi: 10.12688\/f1000research.17228.","DOI":"10.12688\/f1000research.17228.1"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Thanert R, Keen EC, Dantas G et al. Necrotizing Enterocolitis and the Microbiome: Current Status and Future Directions. J Infect Dis. 2021;223(12Suppl2):S257-S263. doi: 10.1093\/infdis\/jiaa604.","DOI":"10.1093\/infdis\/jiaa604"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Feng B, Zhang Z, Wei Q et al. A prediction model for neonatal necrotizing enterocolitis in preterm and very low birth weight infants. Front Pediatr. 2023;11:1242978. doi: 10.3389\/fped.2023.1242978.","DOI":"10.3389\/fped.2023.1242978"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med.. 2011;364(3):255\u2013264. doi: 10.1056\/nejmra1005408.","DOI":"10.1056\/nejmra1005408"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Mavropulo TK. Nekrotyzuiuchyi enterokolit novonorodzhenykh - problemy diahnostyky. [Necrotizing enterocolitis of newborns \u2013 problems of diagnosis]. Neonatolohiya, khirurhiya ta perynatal'na medytsyna. 2017;7:4(26):95-101. doi: 10.24061\/2413-4260.VII.4.26.2017.17. (Ukrainian)","DOI":"10.24061\/2413-4260.vii.4.26.2017.17"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Tirone C, Pezza L, Paladini A et al. Gut and Lung Microbiota in Preterm Infants: Immunological Modulation and Implication in Neonatal Outcomes. Front Immunol. 2019;10:2910. doi: 10.3389\/fimmu.2019.02910.","DOI":"10.3389\/fimmu.2019.02910"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Patel RM, Ferguson J, McElroy SJ et al. Defining necrotizing enterocolitis: current difficulties and future opportunities. Pediatr Res. 2020;88(1):10-15. doi: 10.1038\/s41390-020-1074-4.","DOI":"10.1038\/s41390-020-1074-4"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Tewari VV, Dubey SK, Kumar R et al. Early versus Late Enteral Feeding in Preterm Intrauterine Growth Restricted Neonates with Antenatal Doppler Abnormalities: An Open-Label Randomized Trial. J Trop Pediatr. 2018;64(1):4-14. doi:10.1093\/tropej\/fmx018.","DOI":"10.1093\/tropej\/fmx018"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. El Hassan NO, Tang X, Gossett J et al. Necrotizing Enterocolitis in Infants with Hypoplastic Left Heart Syndrome Following Stage 1 Palliation or Heart Transplant. Pediatr Cardiol. 2018;39(4):774-785. doi: 10.1007\/s00246-018-1820-0.","DOI":"10.1007\/s00246-018-1820-0"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Cai N, Liao W, Chen Z et al. The Mean Platelet Volume Combined with Procalcitonin as an Early Accessible Marker Helps to Predict the Severity of Necrotizing Enterocolitis in Preterm Infants. Int J Gen Med. 2022;15:3789-3795. doi: 10.2147\/IJGM.S346665.","DOI":"10.2147\/ijgm.s346665"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Gong X, Chen X, Wang L et al. Analysis of clinical features of neonates with congenital heart disease who develop necrotizing enterocolitis: a retrospective case-control study. Ann Transl Med. 2022;10(16):879. doi: 10.21037\/atm-22-3248.","DOI":"10.21037\/atm-22-3248"}],"container-title":["Wiadomo\u015bci Lekarskie"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T17:09:30Z","timestamp":1714583370000},"score":1,"resource":{"primary":{"URL":"https:\/\/wiadlek.pl\/wp-content\/uploads\/archive\/2024\/WiadLek2024i3.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024,3]]}},"URL":"https:\/\/doi.org\/10.36740\/wlek202403106","archive":["Internet Archive"],"relation":{},"ISSN":["0043-5147"],"issn-type":[{"value":"0043-5147","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}